Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Petros Pharmaceuticals ( (PTPI) ) has issued an announcement.
Petros Pharmaceuticals, Inc. announced that its common stock will be delisted from the Nasdaq Stock Market, effective ten days after the filing of Form 25 with the Securities and Exchange Commission. The stock, which was suspended from Nasdaq trading in May 2025, has been trading on the OTCID Basic Market since July 2025 and will continue to do so without disruption, while the company remains subject to certain reporting obligations.
More about Petros Pharmaceuticals
Average Trading Volume: 328,632
Technical Sentiment Signal: Sell
Current Market Cap: $826.3K
Learn more about PTPI stock on TipRanks’ Stock Analysis page.